Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Amortizatization of Intangibles (2023 - 2025)

Immunome (IMNM) has disclosed Amortizatization of Intangibles for 3 consecutive years, with -$2.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortizatization of Intangibles fell 193.66% year-over-year to -$2.4 million, compared with a TTM value of $489000.0 through Dec 2025, down 83.13%, and an annual FY2025 reading of $489000.0, down 83.13% over the prior year.
  • Amortizatization of Intangibles was -$2.4 million for Q4 2025 at Immunome, down from $2.6 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $2.6 million in Q3 2025 and bottomed at -$2.4 million in Q4 2025.
  • Average Amortizatization of Intangibles over 3 years is $304916.7, with a median of $99000.0 recorded in 2025.
  • The sharpest move saw Amortizatization of Intangibles skyrocketed 896.3% in 2024, then plummeted 193.66% in 2025.
  • Year by year, Amortizatization of Intangibles stood at $603000.0 in 2023, then surged by 316.09% to $2.5 million in 2024, then crashed by 193.66% to -$2.4 million in 2025.
  • Business Quant data shows Amortizatization of Intangibles for IMNM at -$2.4 million in Q4 2025, $2.6 million in Q3 2025, and $83000.0 in Q2 2025.